Navigation Links
CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
Date:8/27/2007

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today the completion of enrollment of its pivotal clinical study for the treatment of atrial fibrillation.

Ed Brennan, Ph.D. Chief Executive Officer of CryoCor, said, "This is a major milestone for CryoCor, being the first company to complete enrollment in a randomized pivotal study for the use of ablation for the treatment of atrial fibrillation. Completion of enrollment confirms our lead over other companies conducting atrial fibrillation ablation pivotal trials and brings us one step closer to our goal of bringing our product to market for the treatment of atrial fibrillation. With the recent approval of our cryoablation system for the treatment of right atrial flutter, in the fourth quarter, we will begin placing our system at high volume ablation centers across the U.S., familiarizing physicians with our system and establishing our installed base of consoles in anticipation of approval for the treatment of atrial fibrillation in 2009."

Helen Barold, M.D. Chief Medical Officer of CryoCor, said, "I am very pleased with the progress we have made with this study and look forward to fully analyzing the data. We continue to see an excellent safety profile for our cryoablation device and expect to file a PMA in late 2008. At this point we will begin our non-randomized continued access protocol in which patients will be enrolled into the ablation arm. "

CryoCor has enrolled over 170 patients in its pivotal clinical study and will complete a 12-month follow up for each patient.

About CryoCor

CryoCor is a medical technology company that has developed and manufactures a disposable catheter system based on its proprietary cryoablation technology for the minimally invasive treatment of cardiac arrhythmias. The Company's product, the CryoCor Cardiac Cryoablation System, or the Cryoa
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Dec. 1 The new position of Execu...ip Biotechnologies, Inc. has been taken up by Howa... more than 30 years of experience creating and man...stein will direct Microchip Biotechnologies, marke...vice operations as the company makes the transitio...
(Date:12/1/2009)...1 CCS Medical, Inc. a leading dire... announced that it has received approval from the ...aware (the "Court") for its bidding procedures in ... substantially all of its assets. ,, Pursuant t...oved bidding procedures for the sale of substantia...
(Date:12/1/2009)...swire-FirstCall/ -- CryoLife, Inc. ( CRY) , an im...ular tissue processing company, announced its init... expects total revenues for the full year of 2010 ...hich includes between $1.5 million and $2.5 millio...of Defense in connection with the development of B...
Breaking Medicine Technology:Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 1Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 2Abbott and AstraZeneca Extend Relationship to Include Co Promotion of TRILIPIX 28R 29 28fenofibric acid 29 47895 3St Louis Firm Brings Medicare Risk Adjustment to iPhone 47892 1St Louis Firm Brings Medicare Risk Adjustment to iPhone 47892 2SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 1SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 2SignatureForum Reveals Top Rated Aesthetic Medical Practices in U S 47889 3
...YOQNEAM, Israel and SAN RAMON, California, April 3...al study of the,UltraShape(R) Contour I, the first...eduction and body contouring using non-thermal sel... American Society for Laser Medicine and,Surgery a...da. The,presentation is entitled "Lipotripsy: Non-...
...NEW BRUNSWICK, N.J., April 2, 2008 Senesco,Techno...SNT ) announced today,that Dr. Raghavendra Mirmira... presenting his findings regarding preclinical pan...l 2008. Dr. Mirmira, who conducted this,preclinica... presently the,Eli Lilly Endowed Chair in Pediatri...
Other Medicine Technology:UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 2UltraShape(R) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Featured at American Society for Laser Medicine and Surgery Meeting 3Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 2Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences 3
(Date:12/1/2009)...ASHINGTON, Dec. 1 The K...linic in Los Angeles, has agreed to pay the United...eceived illegal kickbacks from HealthSouth Corpora... ,, The settlement resolves allegations that He...m of stock option grants, donations to the Kerlan ...
(Date:12/1/2009)...LOS ANGELES, Dec. 1 A decision iss...abor Relations Board (NLRB) has put at risk the gu... of Kaiser Permanente RNs, social workers, and pro...worked for years to achieve standards at Kaiser th...ofessional care our patients need," said Jeanette ...
(Date:12/1/2009)...y research suggests that criteria based on compute...m colorectal liver metastases after chemotherapy w... predict overall survival, according to a study in... of bevacizumab to cytotoxic (toxic to cells) chem...atients with stage IV colorectal cancer and higher...
(Date:12/1/2009)..., NEW ORLEANS, Dec. 1 /PRNewswire-USNewswire/ -...st its annual High School Student Symposium at the...8:00 a.m. CST. The symposium, which encourages an ...nd medical research, is held in conjunction with t...nts will have the opportunity to explore research ...
(Date:12/1/2009)... MEXICO CITY, Dec. 1 The governmen...orld-class center for biomedical and nanomedical r...for medical research and development will be integ...exico, the top Spanish speaking university in the ...onstruction in 2010, has been designed by the inte...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:Labor Board Decision Puts Kaiser Workers' Pay, Healthcare, Pensions in Jeopardy 2Health News:Criteria based on CT imaging after chemotherapy may help predict survival 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Mexico City to Build World-Class Hub for Medical Research 2
... export of herbal products and medicines has the p...current Rs.30 billion with the creation of exclus...s a study. Herbal product exports can be ..., Spain, Australia, Russia and Indonesia, said the...
...ay at the 61st Annual Meeting of the Society for V...Cordis Corporation, announced the worldwide launch...n Catheter for use in angioplasty procedures for p...e (RX) or single operator system that facilitates ...
... number of suicide attempts among asylum seekers i... what is a "desperate cry of despair," according t... asylum seekers of the 10,797 refugees living in c... That contrasted with the 2006 figures, when 41 pe...
...an, a TATA company, is in negotiations with Prof V...eer attached to the University of Arkansas, to sta...re in the final stages. The deal is yet to be fina...s Center (HiDEC) and Neurosurgery Research Program...
... Meningitis Vaccine Project (MVP) today released n... in West African children, suggesting that the ne...s a dose --will be much more effective in protecti...Organization (WHO) and the Seattle-based non-profi...
...OTT PARK, Ill., Abbott announced today that it has...n Commission for the use of HUMIRA(R) (adalimumab...A is the first self-administered biologic for the ...e. This announcement follows FDA approval for the ...
Other Medicine News:Health News:Export of Herbal Products to Reach Rs.120 Billion by 2012: Study 2Health News:New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty 2Health News:Titan may Produce Glucose Watches Soon 2Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 2Health News:Improved Meningitis Vaccine for Africa Expected to End Deadly Scourge 3Health News:Abbott's Humira(r) (Adalimumab) Gets Approval by EU for Crohn's Disease Treatment 2
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: